| Name | Title | Contact Details |
|---|
Get a personalized medical team of experts that tests for and treats the earliest signs and avoidable symptoms associated with chronic disease and aging.
MemoryWell is a digital platform that uses life storytelling to improve the care of elders. Using our network of more than 700 professional writers, we work with families, senior living communities and home- and community-based providers to replace burdensome intake questionnaires with brief, intimate stories designed to build empathy and be poignant keepsakes for families. Families can add to them their loved one`s favorite photos, music and movies so whomever is sitting with them—whether it`s a paid caregiver, or a grandchild—they have a whole toolbox of things with which to engage that senior.
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.